A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Multiple Subcutaneous Doses of OLP-1002
Clinical trial NCT04677933 · COMPLETED
Trial details
- NCT number
- NCT04677933
- Sponsor
- OliPass Australia Pty Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-03
- Primary completion
- 2020-12-22
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.